Lucky Energy | $25,000,000 | (Nov 13, 2025)
Vend Park | $17,500,000 | (Nov 13, 2025)
BoomPop | $41,000,000 | (Nov 13, 2025)
Carthera
France
- PARIS, IDF
- 27/06/2023
- Series B
- $41,077,875
Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders.
Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain.
By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS).
The products developed by Carthera® are in clinical or preclinical evaluation (not FDA or CE approved) and are not available for sale.
- Industry Medical Equipment Manufacturing
- Website https://carthera.eu/
- LinkedIn https://www.linkedin.com/company/carthera/
Quality Means Business | $2,000,000 | (Nov 13, 2025)
REBEL | $25,000,000 | (Nov 13, 2025)
Modulight Biotherapeutics | $12,000,000 | (Nov 13, 2025)
Frugal | $5,000,000 | (Nov 13, 2025)
Humanix | $18,000,000 | (Nov 13, 2025)
Ladder Bio Inc. | $5,500,000 | (Nov 13, 2025)
GC AI | $60,000,000 | (Nov 13, 2025)
BITE Data | $2,500,000 | (Nov 11, 2025)
EVE(1) | $2,000,000 | (Nov 11, 2025)